Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Randomised Controlled Trial to Explore the Ideal Individualized Anti-hypertension Strategies in Patients With Severe Stroke at Acute Stage

NCT02982655 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT02982655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02982655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Randomised Controlled Trial to Explore the Ideal Individualized Anti-hypertension Strategies in Patients With Severe Stroke at Acute Stage
Lead sponsor
Xijing Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2017
Completion date
November 30, 2018
Enrollment
500 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke, hypertension, severe stroke